Bioverativ U S L L C

FDA Filings

This page includes the latest FDA filings for Bioverativ U S L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device Company	Device	Date
Enjaymo Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH	Prescription Medication	2023-05-26
Enjaymo Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH	Prescription Medication	2023-02-08
Enjaymo Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH	Prescription Medication	2022-03-15
Enjaymo Bioverativ U.S. LLC., Biogen MA Inc., Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen), KBI Biopharma, Inc., Genzyme Corporation, Eurofins Biopharma Product Testing Munich GmbH, Sanofi-Aventis Deutschland GmbH	Prescription Medication	2022-02-08
NDC 80203-347 Bioverativ U.S. LLC.	Enjaymo	2022-02-04

Similar & Related FDA Registered Companies

Related Finance Registrations

NCAGE Code	7ZXA3	BIOVERATIV U.S. LLC.
CAGE Code	7ZXA3	BIOVERATIV U.S. LLC.
S.A.M. Registration	7ZXA3 [80521844]	BIOVERATIV U.S. LLC.

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.